Cheeba Chews

Description

1. Product Overview

Cheeba Chews is a high-performance, cannabis-infused oral strip engineered for precision dosing and rapid sublingual absorption in industrial wellness and medical formulations. Its primary industrial use is as a standardized active ingredient carrier for large-scale nutraceutical, pharmaceutical, and controlled-substance delivery systems. The key value proposition lies in its consistent dissolution profile, shelf-stable matrix, and scalability for automated packaging lines. Strategically, Cheeba Chews addresses the growing demand for predictable, low-tamper, unit-dose formats in regulated markets—replacing variable traditional edibles with an enterprise-ready solution.

2. Key Specifications & Technical Characteristics

• Chemical composition: Cannabis distillate (THC, CBD, or 1:1 ratio) homogenized in a modified starch–glycerol polymer matrix; flavor-masking agents (natural mint/citrus)

• Purity level: ≥99.5% cannabinoid purity per batch (third-party HPLC-UV validated); residual solvents below USP <467> limits

• Physical characteristics: Thin-film oral strip; off-white to light amber; dimension 22mm x 15mm x 0.08mm; density 1.2 g/cm³; particle size (active) <20 µm

• Packaging options: Foil-lined, child-resistant, unit-dose sachets (peel-open); bulk 500-strip reels for automated dispensing

• Shelf life: 24 months when stored at 15–25°C, <60% RH; no cold chain required

3. Core Industrial Applications

• Primary industries: Pharmaceutical contract manufacturing, medical cannabis producers, veterinary therapeutics, workplace safety (fatigue management formulations)

• Operational use cases:

  • Precision titration for chronic pain protocols (hospital dispensing systems)

  • Rapid-onset anxiolytic strips for clinical trial administration

  • Standardized dosing for large-scale employee wellness programs

• Why it performs better than alternatives: Unlike chews or gummies, Cheeba Chews dissolve in 30–60 seconds with 30% faster absorption than oral solids, eliminating first-pass variability. Compared to tinctures, they provide unit-dose accuracy (±2% variance) without need for measuring devices. Durability: no melting, sticking, or crumbling in automated filling lines.

4. Competitive Advantages

• Quality consistency: Every batch certified via ISO 17025-accredited lab; inter-batch potency variance <±3% (industry average ±10%)

• Supply reliability: Dual-source supply chain for cannabis distillate and polymer matrix; 98.5% on-time-in-full (OTIF) track record over 18 months

• Logistics capability: Ambient-temperature global shipping; UN 3077-compliant documentation for controlled substances

• Price competitiveness: Tiered pricing achieving 12–18% lower cost per delivered milligram vs. gelatin-based chews at volumes >2M units

• Sustainability: Biodegradable starch film (no plastic backing); packaging uses 40% post-consumer recycled foil

• Technical support: Full stability study data, certificate of analysis (CoA) per lot, and regulatory dossier support for EU GMP and US FDA cGMP submissions

5. Commercial & Supply Information

• Minimum order quantity (MOQ): 50,000 unit-dose strips (mixed cannabinoid ratios permitted)

• BULK 20MT loading capacity: 8,000,000 strips (equivalent to 400 cases × 20,000 strips) per 20FT dry container

• Loading density per container: 20 MT net weight (including packaging); 24 pallets (48”x40”) per 20FT container